Resistencia a drogas de Mycobacterium tuberculosis

Estos son algunos de los artículos que podría utilizar para la redacción del artículo, sin embargo, su uso dependerár de la disponibilidad de éstos en línea.

1. Murphy DJ, Brown JR..Novel drug target strategies against Mycobacterium tuberculosis. Curr Opin Microbiol. 2008 Sep 15


2. Grant A, Gothard P, Thwaites G. Managing drug resistant tuberculosis. BMJ. 2008 Aug 28;337:a1110. doi: 10.1136/bmj.a1110. Review.


3. Hernandez C, Cetner AS, Jordan JE, Puangsuvan SN, Robinson JK.Tuberculosis in the age of biologic therapy. J Am Acad Dermatol. 2008 Sep;59(3):363-80; quiz 382-4. Review.


4. Rodríguez JC, García-Pachon E, Ruiz M, Royo G. Drug susceptibility of the Mycobacterium genus: in vitro tests and clinical implications. Curr Clin Pharmacol. 2006 Sep;1(3):277-89. Review.


5. Ani AE, Idoko J, Dalyop YB, Pitmang SL. Drug resistance profile of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Jos, Nigeria. Trans R Soc Trop Med Hyg. 2008 Sep 11.


6. Schell RF, Nardelli DT, DeCoster DJ, Kirk SM, Callister SM. Mycobacterium tuberculosis susceptibility testing by flow cytometry. Curr Protoc Cytom. 2004 Feb;Chapter 11:Unit 11.7.


7. Lew W, Pai M, Oxlade O, Martin D, Menzies D. Initial drug resistance and tuberculosis treatment outcomes: systematic review and meta-analysis. Ann Intern Med. 2008 Jul 15;149(2):123-34. Review.


8. Bemer-Melchior P, Bryskier A, Drugeon HB. Comparison of the in vitro activities of rifapentine and rifampicin against Mycobacterium tuberculosis complex.


9. Bosne-David S, Barros V, Verde SC, Portugal C, David HL. Intrinsic resistance of Mycobacterium tuberculosis to clarithromycin is effectively reversed by subinhibitory concentrations of cell wall inhibitors. J Antimicrob Chemother. 2000 Sep;46(3):391-5.


10. Thomsen VO, Bauer J, Lillebaek T, Glismann S. Results from 8 yrs of susceptibility testing of clinical Mycobacterium tuberculosis isolates in Denmark. Eur Respir J. 2000 Aug;16(2):203-8.


11. García-García ML, Ponce de León A, Jiménez-Corona ME, Jiménez-Corona A, Palacios-Martínez M, Balandrano-Campos S, Ferreyra-Reyes L, Juárez-Sandino L, Sifuentes-Osornio J, Olivera-Díaz H, Valdespino-Gómez JL, Small PM. Clinical consequences and transmissibility of drug-resistant tuberculosis in southern Mexico.


12. Granich RM, Balandrano S, Santaella AJ, Binkin NJ, Castro KG, Marquez-Fiol A, Anzaldo G, Zarate M, Jaimes ML, Velazquez-Monroy O, Salazar L, Alvarez-Lucas C, Kuri P, Flisser A, Santos-Preciado J, Ruiz-Matus C, Tapia-Conyer R, Tappero JW. Survey of drug resistance of Mycobacterium tuberculosis in 3 Mexican states, 1997.
    Arch Intern Med. 2000 Mar 13;160(5):639-44.
    

Estudiante QBC. Enrique Wenceslao Coronado Aceves